Last reviewed · How we verify
NCT05240703: TMD
Stabilization Splint Treatment of TMD
NA trial testing Stabilization splint treatment in Temporomandibular Disorder in 80 participants. Completed in 31 August 2010.
31 August 2010
Quick facts
| Lead sponsor | University of Oulu |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 80 |
| Start date | 1 March 2008 |
| Primary completion | 31 August 2010 |
| Estimated completion | 31 August 2010 |
Drugs / interventions tested
- Stabilization splint treatment
Conditions studied
- Temporomandibular Disorder — all drugs for Temporomandibular Disorder →
- Facial Pain — all drugs for Facial Pain →
Sponsor
University of Oulu
Who can join
20 and older, any sex, with Temporomandibular Disorder or Facial Pain. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this randomized controlled trial was to assess the efficacy of stabilization splint treatment on TMD-related facial pain and oral health-related quality of life during a one-year follow-up. Eighty TMD patients were randomly assigned to two groups: splint group (n=39) and control group (n=41). The patients in the splint group were treated with a stabilization splint and received counseling and instructions for masticatory muscle exercises. The controls received only counseling and instructions for masticatory muscles exercises. The outcome variables were the intensity of facial pain (as measured with visual analogue scale, VAS), patients' subjective estimate of symptoms and treatment outcome, as well as Oral Heath Impact Profile (OHIP)-14. The differences in variables between the groups at each follow-up points (1 month, 3 months, 6 months and 1 year after baseline) were analyzed using regression models. Group status and presence of psychosocial symptoms were included as the explanatory factor and baseline VAS, gender, age, length of treatment and general health status as confounders.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05240703
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Temporomandibular Disorder
Currently open trials in the same condition.
- NCT06941636 — Botulinumtoxin A as a Treatment for Myalgia and Myofacial Pain in Patient With Temporomandibulardisorders · Phase 3 · recruiting
- NCT03849534 — Treatment of Temporomandibular Disorders in Children and Adolsecents · NA · recruiting
- NCT06214923 — Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG) · NA · recruiting
- NCT06365151 — An Algorithm for Approaching Temporomandibular Disorders With Osteopathic Manual Therapy in Patients With Fibromyalgia · NA · recruiting
- NCT06357702 — K23- Physical Self Regulation vs Placebo · NA · recruiting
Other University of Oulu trials
Trials by the same sponsor.
- NCT07381933 — The Effect of Consumed Berries on Extracellular Vesicle Signalling in the Body · NA · recruiting
- NCT07280624 — Diagnostic PCR Panel in Children With Acute Gastrointestinal Symptoms · NA · not yet recruiting
- NCT05494684 — Effectiveness of Multisensoral Nature-based Intervention in Hospitalized Children During Venous Blood Sampling · NA · not yet recruiting
- NCT06711393 — The Effectiveness of Exergaming for Older People Mobility and Balance · NA · not yet recruiting
- NCT06171867 — PNEUMACRIT Device for Neonatal Cardio Respiratory Monitoring · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05240703 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Oulu
- Last refreshed: 15 February 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05240703.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing